York Instruments Signs Agreement for Three Magnetoencephalography Systems with Consortium of Leading Universities

YORK UK, Aug. 8, 2017—York Instruments, Ltd. (subsidiary of Croton Healthcare, LLC, Coral Springs, Florida) has signed agreements to place magnetoencephalography (MEG) systems at three leading neuroscience research universities in the UK and Germany. The University of York and the University of Glasgow in the UK and Germany’s University of Konstanz will partner closely with York Instruments to develop the ground-breaking technology, as well pursue potential new applications using the company’s recently released MEG technology.

The agreement expands upon a development partnership started in 2015. By first incorporating MEGSCAN™ core control electronics, the universities’ MEG researchers will achieve an improved signal to noise ratio through ground breaking low noise electronics. With the full MEGSCAN™ system, the universities will end their reliance on expensive liquid helium, a dwindling non-renewable resource, and have the capability to measure healthy and pathological brain signals with unprecedented sensitivity.

York Instruments’ CEO Gordon Baltzer said, “We are very pleased to be able to invite the Universities of York, Glasgow and Konstanz to be part of our growing network of pioneering MEG research and clinical sites worldwide looking to radically improve the field of MEG.”

Later this year, the universities will install the first stage of control electronics, which will allow for higher levels of functional brain imaging. In addition to offering unprecedented low levels of electronic noise interference, the systems have a higher level of reliability, lower power consumption and will be upgradable to future revisions.

About York Instruments Ltd.
York Instruments is a UK-based company specializing in magnetic measurements and their healthcare applications. Using the very latest technologies and methodologies, York instruments is focused on magnetoencephalography and its ability to effectively assess interruptions to neural networks. York Instruments’ revolutionary MEG technology allows for earlier and improved diagnostic capability in relation to a variety of neurological diseases and conditions. Additional information is available at www.york-instruments.com.

Media Contact
Tyler Lecceadone
SeyferthPR
lecceadone@seyferthpr.com

York Instruments receives first order for its magnetoencephalography instrument from the University of Texas Southwestern Medical Center

March 21, 2017 (York UK) —York Instruments Ltd. (subsidiary of Croton Healthcare, LLC, Coral Springs, FL) has received its first order for a MEGSCAN™ magnetoencephalography (MEG) instrument. The purchase was made by the prestigious University of Texas Southwestern Medical Center in Dallas, Texas (UTSW). York Instruments’ newly developed MEG system maps brain activity by recording magnetic fields produced by electrical currents occurring naturally in neurons of the brain.

York Instruments’ Vice President of Global Sales and Marketing Gordon Haid said, “We are extremely happy to be working closely with the talented individuals at UTSW as we install York Instruments’ new MEG platform. As the first member of our MEGSCAN™ beta site program, we expect to collaborate extensively with UTSW on the development of the technology and expanding indications for MEG.”

The MEGSCAN™ will be installed at UTSW later this year, where it will be used for both neuroscience research and eventually routine clinical evaluations of patients suffering from epilepsy and other debilitating illnesses. The system incorporates patented HyQUID™ sensor technology in a liquid helium-free cryogenic environment, high-density cortical coverage, integrated simultaneous EEG, new state of the art electronics capability and an advanced software infrastructure.

More info

York Instruments presents at ACMEGS 2017

York Instruments attended the annual American Clinical MEG Society (ACMEGS) conference in Phoenix, Arizona on February 9 to present the latest developments of the company and the MEGSCAN system.

The primary objective of ACMEGS is to support MEG service providers with facility and business operations by networking patients, physicians, and health care administrators with MEG providers. They educate members and other organizations about varying rules, regulations, and reimbursement matters that affect the success of MEG facilities in the US. The society collaborates with ACNS, NAES, AAN, AES and others on matters affecting patient care. Furthermore, they work on new applications of MEG to improve the health of all patients who would benefit from this technology.

York Instruments announces collaboration with eemagine GmbH in MEG-EEG instrumentation and software development

February 8, 2017 (York, UK) – Officials from York Instruments Ltd (subsidiary of Croton Healthcare, LLC, Coral Springs, FL) announced today that the company has entered into an agreement with eemagine GmbH for the development of high performance integrated solutions to study human electromagnetic brain activity using magnetoencephalography (MEG) and electroencephalography (EEG) for research and clinical diagnostics.

This joint effort enables York Instruments to provide users with high-resolution EEG measurements and clinical analysis software, which complements the company’s advanced MEG solutions.

York Instruments’ President James R. Petite Jr. said, “The collaboration with eemagine GmbH is an important milestone toward the upcoming release of York instruments’ MEGSCAN complete package solution.”

More info

York Instruments attends AES annual meeting in Texas

American Epilepsy Society (AES) allows epilepsy clinicians and researchers from around the world to share the most up to date information on clinical resources, epilepsy research and patient support. York Instruments had a strong presence at this years’ meeting, sharing the latest on our new MEGSCAN instrument with doctors and university attendees. The AES meeting took place in Houston Texas from Dec 2nd to Dec 6th.

Epileptologists and neurosurgoens agree that magnetoencephalography is a powerful and effective tool for use in localising epileptic activity:

  • Non-invasive tool to localize epileptic activity & brain function
  • Leads to improved surgical outcomes
  • Direct measure of electrophysiology
  • Data undistorted by the skull & scalp
  • Millimeter / millisecond accuracy

York Instruments unveils MEGSCAN design at Biomag

During the 20th International Conference on Biomagnetism (BIOMAG2016), recently held in Seoul, Korea, York Instruments unveiled images of the groundbreaking MEGSCAN instrument.  Attendees universally had a strong positive reaction to the design, along with the specification highlights:

  • 320 axial gradiometer or magnetometer sensors, each at an independent location over the surface of a whole-cortex helmet.  The highest density, and therefore highest spatial resolution, of any commercially available MEG.
  • Alternate head sizes available as a build-time option, for example for pediatric MEG.
  • 32 reference channels for superior environmental interference cancellation, even at noisy sites.
  • HyQUID detectors with better low frequency and white noise performance than traditional SQUIDs.  Also, HyQUIDs do not need to be retuned while the system is cold.
  • Seated and supine measurement position with separate bed and chair, conveniently accommodating various subject sizes.
  • Cooling via a vibration-free pulse tube, so the system is entirely liquid Helium free.  No expensive liquid helium deliveries; no time-consuming refilling; no complicated and costly recycling.

Croton Healthcare, York Instruments and Simon Fraser University undertaking a clinical study evaluating MEG for diagnosing concussion brain injuries

SURREY, BRITISH COLUMBIA, September 29, 2016—Scientists from Simon Fraser University (SFU) and Croton Healthcare Canada Inc. (Croton) will collaborate to study breakthroughs in concussion diagnosis. The team will examine the effectiveness of novel diagnostic techniques using magnetoencephalography (MEG), a brain imaging technology that SFU has been helping to lead the development of for more than a quarter century. The study will focus on determining the ability to predict chronic symptoms of concussion and more serious traumatic brain injuries. Results will be integrated with those of other institutions, to confirm multi-center reproducibility.

“We are very excited to be working closely with SFU for the advancement of diagnosis and evaluation of concussion,” said Gordon Haid, Vice President of Croton. “It is estimated that over three million individuals sustain a concussion annually in North America. We are eager to take this first step toward finding better ways to diagnose the extent of brain injury, while being committed to improving the quality of care moving forward.”

More info

York Instruments MSR installation

York Instruments’ “special delivery” At York Science Park

York Press reported on the installation of a magnetically-shielded room at York Instruments in August. The installation had its challenges! Eventually a second floor window was removed so that a series of heavy mumetal panels from German MSR installer Vacuumschmelze could be transported into the building. We are pleased to announce that the installation was a success and testing is well underway using the new shielded room.

More info

York Instruments Launches New MEG Device

SUPERCONDUCTOR WEEK   JULY 23, 2016 Vol. 30, No.6

The UK Company York Instruments Ltd. has announced the development of a new magnetoencephalography (MEG) device that employs technology licensed from the University of the York and Royal Holloway University of London. MEG is considered the world’s most sensitive functional brain imaging device. The York MEG uses an improved sensor called a hybrid quantum interference device (HyQUID) that requires no cryogens and incorporates LTS technology.

The HyQUID is much more sensitive, and has a lower noise floor than the traditional superconducting quantum interference device (SQUID) sensors that have been used in MEG systems to date. HyQUIDs are suitable for all applications where SQUIDs would be employed as sensors; however, they have substantially less low-frequency noise, allowing for recordings of slow wave activity for resting state studies. This makes them especially suitable for clinical applications where slow waves are symptomatic of underlying pathology.

More info

York Instruments and UC San Diego formalise strategic software agreement for launch of new MEG system

CORAL SPRINGS, FLA. – July 14, 2016 – York Instruments, Ltd. (York), a Croton Healthcare company, has entered into an exclusive licensing agreement with the University of California San Diego (UC San Diego) for the inclusion of the university’s VESTAL and Fast-VESTAL patent pending methods and software platform into York’s newly developed Magnetoencephalography (MEG) system, which maps brain activity by recording magnetic fields produced by electrical currents occurring naturally in neurons of the brain.

“We are very excited to be working closely with the University of California San Diego for the advancement of York’s MEG platform, and in particular for the expansion of our capability in the diagnosis and evaluation of mild traumatic brain injury (mTBI)” said Gordon Baltzer, chairman and CEO of Croton Healthcare, LLC, parent company of York.

More info

The York Difference

The new MEG is an unprecedented combination of modern sensors, cryogenics, electronics and software. It offers highly improved data quality and accuracy; opens the door to previously unachievable applications; lowers operating cost; and increases versatility.

The York Instruments MEG is more than simply state-of-the-art. Be prepared.